News & Updates

Show Multimedia Only

Physical activity good for COPD

29 Jul 2023

Initiation of moderate-to-vigorous physical activity (MVPA) can help lower the risks of mortality and severe exacerbations for patients with chronic obstructive pulmonary disease (COPD), as reported in a study.

29 Jul 2023

Add-on dupilumab cuts exacerbations in patients with COPD, type 2 inflammation

26 Jul 2023 by

Add-on dupilumab significantly reduced moderate or severe exacerbations in patients with chronic obstructive pulmonary disease (COPD) and type 2 inflammation compared with placebo, according to the BOREAS trial.

26 Jul 2023

SG data: Booster mRNA vax shots shield cancer-affected individuals from COVID-19

25 Jul 2023 by

Administration of booster doses of mRNA-based vaccines provide protection against COVID-19 and its adverse outcomes in patients with cancer who are actively receiving treatment as well as in cancer survivors, as shown in a study from Singapore.

25 Jul 2023

Ηeparan sulphate elevated in acute exacerbations of COPD

25 Jul 2023 by

Circulating levels of heparan sulphate (HS) are higher in patients with acute exacerbations of chronic obstructive pulmonary disease (AECOPD), a study has found. This increase appears to be associated with the aetiology of AECOPD.

25 Jul 2023

Study: Older COVID-19 patients with epilepsy, multimorbidity highly vulnerable

24 Jul 2023

Factors such as older age (>65 years), ventilator use, and higher comorbidity all contribute to increased mortality risk with COVID-19 among patients with epilepsy, as reported in a study.

24 Jul 2023

Ketogenic diet improves gas exchange, sleep apnoea in obesity hypoventilation syndrome

24 Jul 2023

Adherence to a ketogenic diet helps manage hypercapnia and sleep apnoea in patients with obesity hypoventilation syndrome (OHS), claims a nonrandomized crossover study.

24 Jul 2023

Prolonged-release pirfenidone shows therapeutic potential in post–COVID-19 pulmonary fibrosis

22 Jul 2023

A 3-month course of prolonged-release pirfenidone formulation appears to be safe and efficacious in the treatment of patients with postacute sequelae of COVID-19 (PASC)-pulmonary fibrosis, as shown in a study.

22 Jul 2023

Time to recovery from COVID-19 pneumonia similar for abatacept, cenicriviroc, infliximab

15 Jul 2023

Time to recovery from COVID-19 pneumonia does not appear to differ following treatment with abatacept, cenicriviroc, or infliximab among hospitalized patients, according to a study.

15 Jul 2023

OSA treatment with positive airway pressure reduces economic burden in HFpEF

13 Jul 2023

In patients with heart failure with preserved ejection fraction (HFpEF) and comorbid obstructive sleep apnoea (OSA), positive airway pressure (PAP) therapy helps lower the use of healthcare resource, according to a study.

13 Jul 2023

TCM shows potential for mild COVID-19 caused by Omicron

13 Jul 2023 by

Longyizhengqi (LYZQ) granule, a traditional Chinese medicine (TCM), might be a promising drug for the treatment of mild COVID-19 caused by the Omicron variant, a prospective study from China suggests.

13 Jul 2023

News & Updates

Showing Respirology articles

Showing

Specialty:

Physical activity good for COPD

Add-on dupilumab cuts exacerbations in patients with COPD, type 2 inflammation

SG data: Booster mRNA vax shots shield cancer-affected individuals from COVID-19

Ηeparan sulphate elevated in acute exacerbations of COPD

Study: Older COVID-19 patients with epilepsy, multimorbidity highly vulnerable

Ketogenic diet improves gas exchange, sleep apnoea in obesity hypoventilation syndrome

Prolonged-release pirfenidone shows therapeutic potential in post–COVID-19 pulmonary fibrosis

Time to recovery from COVID-19 pneumonia similar for abatacept, cenicriviroc, infliximab

OSA treatment with positive airway pressure reduces economic burden in HFpEF

TCM shows potential for mild COVID-19 caused by Omicron